Cell Cycle
Volume 11, 2012 - Issue 21
Open access
688
Views
17
CrossRef citations to date
0
Altmetric
Cell Cycle News & Views
Cyclin-dependent kinase 4/6 inhibition in cancer therapy
Neil Johnson Department of Medical Oncology; Dana-Farber Cancer Institute and Department of Medicine; Brigham and Women’s Hospital; Harvard Medical School; Boston, MA USA
& Geoffrey I. Shapiro Department of Medical Oncology; Dana-Farber Cancer Institute and Department of Medicine; Brigham and Women’s Hospital; Harvard Medical School; Boston, MA USACorrespondence[email protected]
Page 3913
|
Published online: 03 Oct 2012
Related Research Data
Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH Trial.
Source:
Oxford University Press (OUP)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.